[Carbon dioxide laser treatment of genital intraepithelial neoplasia: A retrospective study].

Traitement des néoplasies intraépithéliales génitales par laser CO2 : étude rétrospective.

Journal

Annales de dermatologie et de venereologie
ISSN: 0151-9638
Titre abrégé: Ann Dermatol Venereol
Pays: France
ID NLM: 7702013

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 23 09 2018
revised: 14 11 2018
accepted: 06 03 2019
pubmed: 20 7 2019
medline: 23 2 2020
entrez: 20 7 2019
Statut: ppublish

Résumé

Genital intraepithelial neoplasias (IEN) are precursors of squamous cell carcinoma. The ideal treatment must be efficacious, conservative and well-tolerated. CO2 laser is one of the recommended therapies, but its efficacy and safety have not been extensively studied. This was a retrospective single-center study. Sixteen patients (8 women and 8 men) treated with CO2 laser for genital IEN, whether high-grade or differentiated, were included. Surgical lateral margins of 3 to 5mm were taken macroscopically during treatment. The CO2 laser session, assessment of therapeutic response and follow-up were undertaken by a dermatologist at the University Hospital of Caen. The mean patient age was 68.1 years and mean follow-up was 52.7 months (5-130). Lesions were isolated in 87.5% of patients. The recurrence rates of genital intraepithelial neoplasia after CO2 laser treatment were 58% for women and 40% for men. No impact on quality of life or on sexual activity was reported in over 90% of patients. Whatever the treatment recommended for intraepithelial neoplasia, recurrence is frequent. CO2 laser is an effective and well-tolerated conservative therapeutic option. It enables rapid clinical remission, but as with all currently available treatments, long-term dermatologic follow-up remains necessary.

Identifiants

pubmed: 31320185
pii: S0151-9638(19)30196-6
doi: 10.1016/j.annder.2019.03.009
pii:
doi:

Types de publication

Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

542-549

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

E Joly (E)

Service de dermatologie, CHU de Caen, avenue de la côte de Nacre, 14033 Caen, France; Faculté de médecine, université de Caen Basse-Normandie, Caen, France. Electronic address: elisa-joly@hotmail.fr.

H Lefranc (H)

Service de dermatologie, CHU de Caen, avenue de la côte de Nacre, 14033 Caen, France; Faculté de médecine, université de Caen Basse-Normandie, Caen, France.

F Comoz (F)

Service d'anatomopathologie, CHU de Caen, 14033 Caen, France.

F Lefort (F)

Service du DIM, CHU de Caen, 14033 Caen, France.

S Pédaillès (S)

Service de dermatologie, CHIC Alençon-Mamers, 61000 Alençon, France.

J-M Chevallier (JM)

Service de dermatologie, CHU de Caen, avenue de la côte de Nacre, 14033 Caen, France.

A Dompmartin (A)

Service de dermatologie, CHU de Caen, avenue de la côte de Nacre, 14033 Caen, France; Faculté de médecine, université de Caen Basse-Normandie, Caen, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH